Trapezoidal cross-sectional spiral microfluidic channels showed high resolution and throughput in cell separation in bio-applications. The main challenges are the complexity and high cost of the fabrication process of trapezoidal cross-sectional channels on the micro-scale. In this work, we present the application of grayscale in microfluidic channel design to overcome the complexity of the fabrication process. We also use direct engraving with a CO₂ laser beam on polymethyl methacrylate (PMMA) material to drastically reduce the microfluidic chip’s cost (to <30 cents) and fabrication time (to 20 min). The capability of the present fabrication methodology for cell sorting applications is demonstrated through experimental tests for the separation of white blood cells (WBCs) from whole blood at different dilution factors. The experimental results indicated that an 800 µL/min flow rate provided the optimal separation efficiency using the fabricated chip. A 90.14% separation efficiency at 1% hematocrit diluted blood sample was reported.

this letter suggests a design methodology for a triple-band wireless power transfer (TB-WPT) filters. The proposed triple-band pass filter (TB-PF) is designed using two complementary split-ring resonators CSRR-DGSs coupled in a back-to-back configuration, and operates at 0.6 GHz, 2.4 GHz, and 2.7 GHz. Each of the transmitter and the receiver has a size of 25 mm × 25 mm. The measured power transfer efficiencies were 96% for 0.6 GHz, 74% at 2.4 GHz, and 70% at 2.7 GHz, respectively, at a separation distance between the transmitter and receiver of 10 mm.

A new highly accurate optical biomedical sensor is proposed for cancer detection characterized by high sensitivity, small footprint, low cost, and low limit of detection. The sensor is based on double-ring resonators made of silicon on insulator. The type of the waveguide is critical in determining the sensor performance. To compromise the advantages and disadvantages of strip and slot waveguides, a mixed design of both has been introduced in literature at the expense of increased footprint compared to traditional sensors. Indeed, almost 27-fold footprint increase is required to improve the sensitivity by only one third of that of slot waveguide’s sensitivity. In this paper, we introduce a new design that keeps the same footprint of traditional sensors, while achieving high sensitivity. This sensitivity depends on the resonance wavelength shift due to different refractive indices of the biosample. It has the value 109.8 nm/RIU compared to 55.57 nm/RIU and 129.621 nm/RIU for strip and slot waveguides, respectively. The hybrid waveguide quality factor is 537.7 while the quality factors of the strip and the slot waveguides are 627.99 and 380.76, respectively. In addition, the new design achieves the minimum limit of detection (0.0255) when compared to that of traditional designs. Furthermore, a new method of detection is proposed with the same design, providing a higher sensitivity over both traditional waveguide types with a value of 15.3, compared to 13.2 and 11.5 for strip and slot waveguides, respectively. In this method, the sensitivity relies on various values of output transmitted light at the same wavelength due to altering the biocell refractive index. The biosensor output equation is developed. In addition, the relationship between the supermodes and the sensitivity is determined at variance conditions. It is found that there is an inverse relation between them.

Accurate, non-invasive glucose monitoring remains a major challenge in biomedical sensing. We present a high-sensitivity planar microwave biosensor that progresses from a 2-cell hexagonal array to an 8-cell hexagonal array, and finally to a 16-cell double-honeycomb (DHC-CSRR) architecture to enhance field confinement and resonance strength. Full-wave simulations using Debye-modeled glucose phantoms demonstrate that the optimized 16-cell array on a Rogers RO3210 substrate substantially increases the electric field intensity and transmission response |S₂₁| sensitivity compared with FR-4 and previous multi-CSRR designs. In vitro measurements using pharmacy-grade glucose solutions (5–25%) and saline mixtures with added glucose, delivered through an acrylic channel aligned to the sensing region, confirm the simulated trends. In vivo, vector network analyzer (VNA) tests were conducted on four human subjects (60–150 mg/dL), comparing single- and dual-finger placements. The FR-4 substrate (${\mathsf{\epsilon }}_{\mathrm{r}}$ = 4.4) provided higher frequency sensitivity (2.005 MHz/(mg/dL)), whereas the Rogers RO3210 substrate (${\mathsf{\epsilon }}_{\mathrm{r}}$ = 10.2) achieved greater amplitude sensitivity (9.35 × 10⁻² dB/(mg/dL)); dual-finger contact outperformed single-finger placement for both substrates. Repeated intra-day VNA measurements yielded narrow 95% confidence intervals on |S₂₁|, with an overall uncertainty of approximately ±0.5 dB across the tested glucose levels. Motivated by the larger |S₂₁| response on Rogers, we adopted amplitude resolution as the primary metric and built a compact prototype using the AD8302-EVALZ with a custom 3D-printed enclosure to enhance measurement precision. In a cohort of 31 participants, capillary blood glucose was obtained using a commercial glucometer, after which two fingers were placed on the sensing region; quadratic voltage-to-glucose calibration yielded R² = 0.980, root–mean–square error (RMSE) = 2.316 mg/dL, overall accuracy = 97.833%, and local sensitivity = 1.099 mg/dL per mV, with anthropometric variables (weight, height, age) showing no meaningful correlation. Clarke Error Grid Analysis placed 100% of paired measurements in Zone A, indicating clinically acceptable agreement with the reference meter. Benchmarking against commercial continuous glucose monitoring systems highlights substrate selection as a dominant lever for amplitude sensitivity and positions the proposed fully non-invasive, consumable-free architecture as a promising route toward portable RF-based glucose monitors, while underscoring the need for larger cohorts, implementation on flexible biocompatible substrates, and future regulatory pathways.